publication venue for
- A Comparison of Yttrium-90 Microsphere Radioembolization to Hepatic Arterial Infusional Chemotherapy for Patients with Chemo-refractory Hepatic Colorectal Metastases.. 18. 2017
- The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.. 16. 2015
- Met, IGF1R, and other new targets in upper GI malignancies.. 14. 2013
- Multidisciplinary management of recurrent chordomas.. 14. 2013
- Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?. 14. 2013
- Considerations regarding the administration of systemic therapy for elderly patients with ovarian cancer.. 14. 2013
- BEYOND KRAS: Other markers and potential treatment strategies for KRAS mutant and wild-type patients.. 12. 2011
- The evolution of multimodality therapy for malignant pleural mesothelioma.. 12. 2011
- Erratum to: Exercise therapy in the management of solid tumors.. 11. 2010
- Advancing Palliative Care Integration in Hematology: Building Upon Existing Evidence. 2023
- Family Meetings in Palliative Care: Benefits and Barriers. 2022
- Cardio-oncology Training in the COVID-19 Era. 2021
- New Treatment Strategies for the Inflammatory Breast Cancer. 2021
- Patient Spirituality as a Component of Supportive Care: Assessment and Intervention. 2020
- Emerging Role of Genomics and Cell-Free DNA in Breast Cancer. 2019
- Optimizing Therapies in the Perioperative Management of Gastric Cancer. 2019
- Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need. 2019
- Systemic Therapy for Advanced Hepatocellular Carcinoma in an Evolving Landscape. 2019
- Low-Grade Serous Ovarian Cancer: Current Treatment Paradigms and Future Directions. 2018
- Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies. 2018
- Options for Adjuvant Therapy for Uterine Leiomyosarcoma. 2018
- The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer. 2017
- Advanced Hepatocellular Cancer: the Current State of Future Research. 2016
- Chemotherapy for Muscle-Invasive Bladder Cancer. 2016
- Current Management and Treatment Modalities for Intramedullary Spinal Cord Tumors. 2015
- The evolving role of cytotoxic chemotherapy in the management of patients with metastatic prostate cancer. 2015
- HER2 directed therapy for gastric/esophageal cancers. 2014
- Systemic treatment options for radiation-associated sarcomas. 2014
- The role of ¹⁸F-FDG PET imaging in upper gastrointestinal malignancies. 2014
- Radiotherapy of follicular lymphoma: updated role and new rules. 2014
- Role of CD30 targeting in malignant lymphoma. 2014
- Update on vaccines for high-risk melanoma. 2014
- Dermatologic adverse events to targeted therapies in lower GI cancers: clinical presentation and management. 2013
- Therapeutic strategies for bone metastases and their clinical sequelae in prostate cancer. 2012
- Exercise therapy in the management of solid tumors. 2010
- Ovarian cancer cytoreductive surgery in the elderly. 2009
- Treatment of advanced thymoma and thymic carcinoma. 2009
- The multidisciplinary management of osteosarcoma. 2009
- Mutational analysis and overcoming imatinib resistance in chronic myeloid leukemia with novel tyrosine kinase inhibitors. 2007
- Prediction of successful outcome in patients with primary aldosteronism. 2007
- Integrating circulating tumor cell assays into the management of breast cancer. 2007
- Cancer of the gastroesophageal junction: Current therapy options. 2006
- Unusual histologic and clinical variants of melanoma: implications for therapy. 2006
- Transperitoneal laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers. 2006
- Management of patients with low-stage nonseminomatous germ cell testicular cancer. 2005
- Therapeutic options for patients with Hodgkin's disease and non-Hodgkin's lymphoma who relapse after autologous transplant. 2005
- Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy. 2004
- Epratuzumab in non-Hodgkin's lymphomas. 2004
- Diagnosis and management of ductal carcinoma in situ. 2004
- Localized and locally advanced bladder cancer. 2002
- Multiple endocrine neoplasia type I. 2002
- Epithelial ovarian cancer. 2002
- Recurrent cervical cancer. 2002
- Advanced renal cell carcinoma. 2001
- Localized renal cell carcinoma. 2001
- Primary central nervous system lymphomas. 2001
- Ewing's sarcoma. 2000
- Advanced ovarian cancer. 2000
- Uterine/female genital sarcomas. 2000